MedPath

Gabapentin

Gabapentin Capsules, USP

Approved
Approval ID

35fee7b8-c127-4345-bae0-bcf46d3b8ccb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 1, 2014

Manufacturers
FDA

ReadyMeds

DUNS: 072115132

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Gabapentin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64205-222
Application NumberANDA090705
Product Classification
M
Marketing Category
C73584
G
Generic Name
Gabapentin
Product Specifications
Route of AdministrationORAL
Effective DateJuly 1, 2014
FDA Product Classification

INGREDIENTS (7)

MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
GABAPENTINActive
Quantity: 300 mg in 1 1
Code: 6CW7F3G59X
Classification: ACTIB
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Gabapentin - FDA Drug Approval Details